PATENT CLAIM ANALYSIS

Application Number: 15962911
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["424", "443000"]

Abstract:
Devices for and methods of treatment of metabolic syndromes are disclosed. Namely, the presently disclosed devices and methods are provided for affecting the function of the gastrointestinal endocrine system in key regions of the gut, thereby, producing therapeutic effects on obesity, diabetes and other metabolic syndromes. In some embodiments, the devices include multilayered bioadhesive patches delivered orally by dissolvable ingestible capsule, wherein various mechanisms are provided for anchoring the bioadhesive patches to the duodenal mucosa.

Claim (Index 15):
The method of  claim 12 , wherein the discrete patches are self-folding.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 91.0
- Lexical Diversity: 1.55556
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15303333', '13780284', '15455080', '14239899', '15624372']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6968255953696139
- 35 USC 102 Novelty (BERT): 0.4884540192972756
- Combined Prediction Score: 0.67598843776238
- Mean Citation Score: 130.97518200000002
- Max Citation Score: 143.7637
- Similarity Product: 90.81480652016994

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test